http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2563796-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c9303a2c93645d26a1c84fb810ca0bd |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G09B23-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 |
| filingDate | 2014-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d79bf29ddd2b5f672998a5e24fcbf1f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca552795ce5f5db57b5790afdef3b7d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dcf6806f8ab71b3060e28aac925ff7e |
| publicationDate | 2015-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2563796-C1 |
| titleOfInvention | Method of treating ischemic hepatic injuries |
| abstract | FIELD: medicine. n SUBSTANCE: hepatectomy using an intraoperative extracorporeal temporal portacaval shunt is performed in an experimental animal. On the day of the surgical intervention, the slow intravenous bolus administration of Heptral, the solution for injections, follows 1.5 hours prior to the surgical intervention in a dose of 2 mg/kg, 2 hours after the first administration - in a dose of 6 mg/kg and 8 hours after the first administration - in a dose of 4 mg/kg. What is also required is the slow intravenous bolus administration of Clarithromycin in NaCl solution 0.5 in a dose of 3 mg/kg three times a day at 7 00 , 15 00 and 23 00 . The postoperative period involves administering Heptral two times a day - at 9 00 in a dose of 7 mg/kg, at 16 00 in a dose of 5 mg/kg; Clarithromycin - three times a day at 7 00 , 15 00 and 23 00 in a dose of 3 mg/kg. The total length of administering Heptral and Clarithromycin is 10 days. n EFFECT: method provides treating, correcting and preventing a surgical infection, ischemic and reperfusion hepatic injuries, lengthening safe periods of liver exsanguinations and avoiding major haemorrhages potentially accompanying the hepatic surgical intervention. n 3 ex, 5 tbl |
| priorityDate | 2014-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 122.